Abstract
During the COVID pandemic, biomedicine and the rapid development of anti-COVID vaccines has been widely praised, while the global public health response has been questioned. Fifteen United States based combined experts in primary healthcare and public health responded to an open question focusing on this issue. Eleven of these experts responded. Four major themes emerged from their answers, including: fragmentation between public health and biomedicine; underfunding of public health; lack of centralized public health authority; business interests over the public good and well-being.
Highlights
Clinical medicine’s goal is the diagnosis and treatment of diseases, while public health aims for the prevention of disease
Fifteen United States based combined experts in primary healthcare and public health responded to an open question focusing on this issue
Four major themes emerged from their answers, including: fragmentation between public health and biomedicine; underfunding of public health; lack of centralized public health authority; business interests over the public good and well-being
Summary
Clinical medicine’s goal is the diagnosis and treatment of diseases, while public health aims for the prevention of disease. Clinical medicine focuses on the individual, while public health focuses on the population. There has been a significant gap between public health and clinical medicine.(1) The COVID-19 pandemic appears to have accentuated this gap. In this qualitative study, the authors ask experts who work simultaneously in medicine and public health their opinion on the public health response and the biomedicine response to the pandemic
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
